Study to Determine the Comparative Pharmacodynamics of Enoxaparin Sodium Biosimilar With That From Clexane

Clinical trial NCT07517289 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07517289
Sponsor: Egyptian International Pharmaceutical Industries Co
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Study The Focus of the Study is to Determine the Comparative Pharmacodynamic of Enoxaparin Sodium With That of Clexane in Healthy Human Participants

Start date: 2026-04-30
Primary completion: 2026-06-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.